Works around the globe to promote the human-animal bond and confront cruelty to animals in all of its forms.

Humane Society International works around the globe to promote the human-animal bond, rescue and protect dogs and cats, improve farm animal welfare, protect wildlife, promote animal-free testing and research, respond to natural disasters and confront cruelty to animals in all of its forms.

Humane Society International

Accessible giving infrastructure for a more generous world.

Follow our realtime impact at https://www.every.org/metrics - people have donated over $36M!

We provide nonprofits with free tools to fundraise more effectively, including our all-in-one donate button and peer-to-peer fundraising solution. Our website encourages individuals to take action and spread generosity by giving monthly and giving out loud to help nonprofits get steady funding and grow awareness. Our open API for fundraising powers a collective research effort to transform fundraising with nonprofit, academic, corporate, and grassroots partners.

We envision a world where every person and organization has the best technology to help them do more good, increasing the global giving rate from 2% to 3% of GDP.

Every.org

Promoting computer user freedom worldwide, and defending the rights of all software users.

Free software developers guarantee everyone equal rights to their programs; any user can study the source code, modify it, and share the program. By contrast, most software carries fine print that denies users these basic rights, leaving them susceptible to the whims of its owners and vulnerable to surveillance.

The FSF provides critical infrastructure and funding for the GNU Project, the foundation of the popular GNU/Linux family of free operating systems and the keystone of the Internet.

Our Campaigns Team creates educational materials about free software, convenes the yearly LibrePlanet conference and goes toe to toe against powerful interests that threaten computer user rights.

Our Licensing & Compliance Lab defends freely licensed software from proprietary hoarding, advises on licensing issues, and certifies devices that Respect Your Freedom.

Free Software Foundation

Our mission (and passion) is helping shelters & rescues find loving adopters for homeless pets!

We’re North America’s largest non-profit pet adoption website. We're on a mission to help homeless pets find loving homes. #adoptapet

Adopt-a-Pet.com

Developing open source privacy technology that protects free expression.

Long before we knew that it would be called Signal, we knew what we wanted it to be. Instead of teaching the rest of the world cryptography, we wanted to see if we could develop cryptography that worked for the rest of the world. At the time, the industry consensus was largely that encryption and cryptography would remain unusable, but we started Signal with the idea that private communication could be simple.

Since then, we’ve made some progress. We’ve built a service used by millions, and software used by billions. The stories that make it back to us and keep us going are the stories of people discovering each other in moments where they found they could speak freely over Signal, of people falling in love over Signal, of people organizing ambitious plans over Signal. When we ask friends who at their workplace is on Signal and they respond “every C-level executive, and the kitchen staff.” When we receive a subpoena for user data and have nothing to send back but a blank sheet of paper. When we catch that glimpse of “Signal blue” on a metro commuter’s phone and smile.

However, we’ve always wanted to do much more, and our limitations have often been challenging. Over the lifetime of the project, there have only been an average of 2.3 full-time software developers, and the entire Signal team has never been more than 7 people. With three client platforms to develop, a service to build and run, a growing list of integrations to assist with, and millions of users to support, that has often left us wanting.

Even so, Signal has never taken VC funding or sought investment, because we felt that putting profit first would be incompatible with building a sustainable project that put users first. As a consequence, Signal has sometimes suffered from our lack of resources or capacity in the short term, but we’ve always felt those values would lead to the best possible experience in the long term. The Signal Foundation completes our vision of Signal operating as part of a full 501(c)(3).

Signal Technology Foundation

In April 2013, our dream became a reality. Fiona Animal Refuge opened its doors with 19 kennels, office and surgery. 

We are 3 retired rock climbing women who have lived in Mexico for about 7 years and witnessed the horrible conditions of the dogs of El Potrero Chico. Not because the people did not care but it was because they had no money or access to vet supplies and services. In 2011, we decided to change that when we found a dog chained to a tree and almost starved to death. After we rescued her and surrounded her with love and care, her little heart gave out. Losing Fiona, her new name, was devastating for all of us and we were determined to change things.

In April 2013, our dream became a reality. Fiona Animal Refuge opened its doors with 19 kennels, office and surgery. To see this beautiful facility really happen and the town embrace our vision is a miracle.  FAR is a 501(c)(3) public charity which means all donations are tax deductible.

The Fiona Animal Shelter supports the idea that the source of abuse, abandonment, mistreatment and cruelty, which most animals are victims of in Mexico, is that the people are not taught how to care for their animals and they do not have access to the resources such as veterinarian services and basic animal care products.  These facts drive us  to reach out to the community for their help.  In exchange, we provide free spay and neuter, vaccinations, flea and tick medication and when necessary, food and shelter. To continue our vision,  we need the support of the people of Mexico and the U.S.

In September 2013, we appeared in Animal Wellness Magazine and have support from OutdoorPlay Sports Company, Rock and Ice Magazine, BarkBox, and Solid Rock Climbers For Christ. All of this because of a dog chained to a tree named Fiona. In her memory, we will make a difference in Mexico.

Fiona Animal Refuge

The Multidisciplinary Association for Psychedelic Studies supports psychedelic and cannabis research, education and policy reform.

Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a visionary 501(c)(3) non-profit organization ushering the safe and ethical use of psychedelics as tools for healing and growth on individual, familial, societal, and planetary levels.

MAPS’ top priority is ethically introducing global access to MDMA-assisted therapy as a treatment for posttraumatic stress disorder (PTSD) through regulatory approvals and training certification for therapy providers, as well as public education, policy reform, and building community support networks.

How Your Donation Will Help

While the MDMA drug development program is the main priority of MAPS, the organization's programs include research into other psychedelic compounds and provide critical resources for researchers around the world interested in studying psychedelics. These resources include assistance with protocol development and regulatory guidance, in addition to providing study drug and training for investigators. As part of its commitment to open science and open praxis, MAPS publishes its research protocols, treatment manual for MDMA-assisted therapy for PTSD, published articles, and investigator's brochure on its website for free download, and actively collaborates with third-party researchers and institutions. Researchers and institutions around the world are building on the body of research that MAPS has produced.

MAPS operates a global network of intersectional education and research programs focused on the careful study of the risks and benefits of psychedelics. The education programs include: harm reduction and peer support through the Zendo Project; policy and advocacy efforts focused on community organizing and reducing barriers to research; a conflict resolution initiative for peace-building; and an active fiscal sponsorship program for fledgling mission-aligned organizations. MAPS also produces myriad educational materials, training workshops, and conferences, both physical and virtual. MAPS builds its global community of support through: outreach at events worldwide; a robust social media presence; and interviews and publications in various global media outlets. All of this work is supported by MAPS’ general operating fund. 

MAPS aims to transcend geopolitical and social boundaries and intentionally cultivates interactions with thought leaders in a broad range of interest areas and outlets that demonstrate the broad applications of the healing potential of psychedelics, and to proactively build trust and common ground with those most likely to have resistance to psychedelics.  

A Tipping Point for Psychedelic Medicine

MDMA-assisted therapy is poised to be a true breakthrough for psychedelic medicine and is the first psychedelic therapy to enter a Phase 3 clinical trial. This trial recently cleared a critical interim evaluation, with analysis confirming a 90% or greater likelihood that the final results will show significant effectiveness in treating PTSD. Achieving FDA approval for this treatment could be the tipping point to shifting psychedelics into the medical mainstream. This shift has the potential to unlock previously unavailable resources for the investigation of psychedelic-assisted treatments applied to our most critical mental health challenges: trauma, depression, addiction, anxiety, and more.

When administered in a clinical setting with trained therapy providers, MDMA has proven to be a powerful adjunct to therapy, which assists individuals in processing traumatic experiences in a deep and profound manner, leading to the alleviation of suffering. Clinical research indicates that MDMA may catalyze therapeutic processing by allowing participants to stay emotionally engaged when revisiting traumatic experiences, without feeling overwhelmed by anxiety or other painful emotions.

FDA approval of MDMA-assisted therapy for PTSD could help millions of people who are suffering from trauma. A long-term follow-up study published in June 2020 demonstrated that 67% of the study volunteers (N=91) who had PTSD for an average duration of 17.8 years were still in remission and no longer qualified for a PTSD diagnosis at least 12-months following the completion of their treatment. 

While MAPS is the engine that powers this research, passionate supporters are the fuel that feeds our fire. We are inspired to press on towards the finish line of this 35-year marathon.

If you have any questions, please email us at giving@maps.org.